MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-02-0048022
Aparna Pharmaceuticals Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹68.42 Cr
▲ 121% YoY
Net loss · FY 2024
₹111.18 Cr
Net margin -162.5%
EBITDA · FY 2024
-₹69.02 Cr
EBITDA margin -100.9%
Authorised capital
₹881 Cr
Registered with MCA
Paid-up capital
₹449.41 Cr
Issued & subscribed
Open charges
₹99.36 Cr
Satisfied ₹2.44 Cr
Company age
6 yrs
Est. 2020
Directors on board
3
As per MCA filings
About Aparna Pharmaceuticals Private Limited
Data last updated:
Aparna Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Aparna Constructions And Estates Private Limited. It operates in the colorants segment of the chemicals and materials sector. It was incorporated on 01 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2020PTC143375. Its GSTIN is 36AATCA9606N1ZV (Telangana). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹881 Cr and a paid-up capital of ₹449.41 Cr. It is led by directors including Pochana Aswin Reddy and Sannareddy Aparna Reddy.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 802 D No 6 – 3 – 352/2 Road No 1 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2024, the company reported a revenue of ₹68.42 Cr, a growth of 121% compared to the previous year. For the same year it recorded a net loss of ₹111.18 Cr (net margin -162.5%) and EBITDA of -₹69.02 Cr (EBITDA margin -100.9%).
Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Aparna Pharmaceuticals. As per MCA filings, the company has open charges of ₹99.36 Cr and satisfied charges of ₹2.44 Cr on record. Court records list 2 cases involving the company, including 2 filed by the company. The company has 5 deals on record (3 rights issues, 2 secondary share transfers); the latest was in March 2025.
Aparna Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-02-0048022). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aparnapharma.com.
Company details
CIN U24304TG2020PTC143375
Registration Number 143375
Incorporation Date 01 September 2020
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Aparna Constructions And Estates Private Limited
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-02-0048022
Key People
Pochana Aswin Reddy Director Sannareddy Aparna Reddy Director Rakesh Reddy Chennuru Director Recognitions & Rankings of Aparna Pharmaceuticals
Contact details
Aparna Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is aparnapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address802 D No 6 – 3 – 352/2 Road No 1 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryChemicals and Materials, Colorants, Dyes & Pigments
To see the full contact details of Aparna Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Aparna Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Aparna Pharmaceuticals operates one associated brand: Aparna Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| API intermediates are manufactured by Aparna Pharmaceuticals as a CDMO. | aparnapharma.com |
Financials of Aparna Pharmaceuticals Private Limited
FY 2025 filings availableAparna Pharmaceuticals Private Limited reported revenue of ₹68.42 Cr (up 121% YoY) for FY 2024.
Revenue · FY 2024
₹68.42 Cr ▲ 121%
Net loss · FY 2024
₹111.18 Cr margin -162.5%
EBITDA · FY 2024
-₹69.02 Cr margin -100.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 121%
Revenue rose 121% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹68.42 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹69.02 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹111.18 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -100.9% | |||
| Net Profit Margin | -162.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Aparna Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aparna Pharmaceuticals Private Limited
Aparna Pharmaceuticals has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pochana Aswin Reddy Also directs: Aparna Mines & Minerals Private Limited, Aparna Chemicals Private Limited, Aparna Laboratories Private Limited and 5 more | Director | 01 Sep 2020 | 6 Years 2 Months | Current |
| Sannareddy Aparna Reddy Also directs: Aparna Transportation Services LLP, Aparna Mines & Minerals Private Limited, Aparna Chemicals Private Limited and 5 more | Director | 01 Sep 2020 | 6 Years 2 Months | Current |
| Rakesh Reddy Chennuru Also directs: Aparna Chemicals Private Limited, Aparna Laboratories Private Limited, Aparna Constructions and Estates Private Limited and 5 more | Director | 01 Sep 2020 | 6 Years 2 Months | Current |
Auditor
Aparna Pharmaceuticals Private Limited is audited by Lalith Prasad and Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Lalith Prasad and Co. | FY 2024 | 08089S |
Shareholding
The shareholding of Aparna Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Aparna Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹99.36 Cr
Satisfied charges
₹2.44 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 May 2024 | 100926957 | Hdfc Bank Limited | ₹21.68 Cr | Open | |
| 12 Apr 2019 | 100257742 | Hdfc Bank Limited | ₹31.68 Cr | Open | |
| 28 Feb 2019 | 100247892 | Hdfc Bank Limited | ₹46 Cr | Open | |
| 30 Sep 2020 | 100406822 | Others | ₹2.44 Cr | Satisfied |
To see the full charge records of Aparna Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Aparna Pharmaceuticals Private Limited has 5 deals on record (3 rights issues, 2 secondary share transfers); the latest was in March 2025.
Total deals
5
Rights issues
3
Secondary share transfers
2
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2025 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Aparna Constructions and Estates Private Limited |
| Mar 2025 | Rights issue | ₹63.64 Cr | Investors: an individual |
| Feb 2023 | Rights issue | ₹293.17 Cr | Investors: Aparna Constructions and Estates Private Limited |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Aparna Constructions and Estates Private Limited Seller: Gamma Organics Limited |
| Nov 2020 | Rights issue | ₹92.45 Cr | Investors: Aparna Constructions and Estates Private Limited , Gamma Organics Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aparna Pharmaceuticals Private Limited has 2 court cases on record: 2 filed by Aparna Pharmaceuticals. All cases are disposed.
Total cases
2
Filed by the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 2 | 0 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Hyderabad | Court case (C.A.(CAA)) | Filed by the company | Disposed |
| NCLT, Hyderabad | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Aparna Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aparna Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Aparna Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Aparna Chemicals Private Limited | U21001TS2023PTC176948 |
To see the full group structure of Aparna Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Aparna Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 28, 2024.
Active EPFO establishments
1
GST
Aparna Pharmaceuticals has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AATCA9606N1ZV | Telangana | Active | 10 Sep 2020 |
| 37AATCA9606N1ZT | Andhra Pradesh | Active | 01 Dec 2023 |
To see the full GST registrations and return filing status of Aparna Pharmaceuticals Private Limited, buy the company report.
Recent activity
Aparna Pharmaceuticals Private Limited has 6 board changes on record since 2020: 3 appointments and 3 cessations. The latest: Subbaraju Gokaraju ceased to be Managing Director on 20 Feb 2021.
AGM
Aparna Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Aparna Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge registered on 30 Sep 2020 via Charge ID 100406822 with Others was fully satisfied on 11 Mar 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 31.68 Cr registered on 12 Apr 2019 with Charge ID 100257742 was modified on 15 Jun 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 21.68 Cr with Charge ID 100926957 was registered on 02 May 2024.
Ceased
Subbaraju Gokaraju ceased to be Managing Director.
Ceased
Yoganandavenkata Somayajulu Nuthi Subrahamanya ceased to be Director.
Ceased
Zia Ansari ceased to be Director.
Charges
A charge with Others amounted to Rs. 2.44 Cr with Charge ID 100406822 was registered on 30 Sep 2020.
Charges
A charge with Hdfc Bank Limited of Rs. 46.00 Cr registered on 28 Feb 2019 with Charge ID 100247892 was modified on 18 Sep 2020.
Appointed
Pochana Aswin Reddy was appointed as Director.
Appointed
Rakesh Reddy Chennuru was appointed as Director.
4 earlier events are in the company report.
News
Frequently asked questions
Aparna Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in colorants, within the chemicals and materials industry. It was incorporated on 01 September 2020 (6+ years old) and is registered under CIN U24304TG2020PTC143375.
Aparna Pharmaceuticals has 3 current directors:
- Pochana Aswin Reddy - Director
- Sannareddy Aparna Reddy - Director
- Rakesh Reddy Chennuru - Director
The latest financial statements of Aparna Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Aparna Pharmaceuticals is 36AATCA9606N1ZV, registered in Telangana. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AATCA9606N1ZT (Andhra Pradesh).
The CIN (Corporate Identification Number) of Aparna Pharmaceuticals is U24304TG2020PTC143375. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aparna Pharmaceuticals has 2 court cases on record: 2 filed by the company.
Aparna Pharmaceuticals was incorporated on 01 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Aparna Pharmaceuticals has 5 deals on record (3 rights issues, 2 secondary share transfers); the latest was in March 2025.
Subbaraju Gokaraju ceased to be Managing Director on 20 Feb 2021. Yoganandavenkata Somayajulu Nuthi Subrahamanya ceased to be Director on 20 Feb 2021. Zia Ansari ceased to be Director on 20 Feb 2021. Aparna Pharmaceuticals has 6 board changes on record in total.
Yes, Aparna Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-TS-02-0048022).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages